U.S. Drug Delivery Devices Market Size, Share, and Industry Analysis – by Product Type, by Application, and by End-use – Growth and Trend Forecast, 2026 -2035

The U.S. drug delivery devices market generated approximately USD 129.2 billion in 2025 and is anticipated to grow to nearly USD 235.4 billion by 2035, reflecting a compound annual growth rate of 6.3% over the forecast period. In 2025, the number of drug administration procedures surpassed 450 million, supported by robust healthcare infrastructure and a high prevalence of chronic conditions. Increasing reliance on patient-controlled therapies and advanced delivery technologies is contributing to market expansion, with both hospital-based services and home healthcare settings playing key roles.

Published: May 6, 2026
100 Pages

Market Overview

Pharmaceutical drug delivery refers to the range of techniques and systems designed to administer therapeutic agents into the body in a controlled and effective manner. The primary objective is to ensure that drugs are delivered at the appropriate dose, site, and timing to achieve optimal clinical outcomes. Traditional approaches include oral formulations, injectable preparations, and topical applications.

Recent technological progress has led to the development of advanced delivery strategies such as controlled-release systems, nanocarrier-based platforms, and site-specific targeting mechanisms, improving precision in therapy.

In the United States, drug delivery systems play a critical role in managing chronic conditions including diabetes, cancer, and cardiovascular disorders, by enabling sustained and regulated drug release. These systems contribute to improved treatment efficacy, enhanced stability of active compounds, and better bioavailability, while minimizing adverse effects.

Additionally, the integration of smart and connected delivery technologies allows monitoring of medication adherence in real time, supports dose optimization, and facilitates personalized treatment approaches.

U.S. Drug Delivery Devices Market Overview

Base Year Market Size (2025): USD 129.2 Billion

CAGR: 6.3%

Forecast Year Market Size (2035): USD 235.4 Billion

Major Players:

  • Becton Dickinson and Company

  • Pfizer Inc.

  • Merck & Co. Inc.

  • 3M

  • Johnson & Johnson

  • Medtronic plc

  • West Pharmaceutical Services, Inc.

  • Baxter International Inc

U.S. Drug Delivery Devices Market Trends

The U.S. pharmaceutical drug delivery sector is currently experiencing a transformative pivot toward decentralized, patient-focused solutions and high-precision biotechnology. As we move through 2026, four foundational pillars are redefining the industry landscape:

· Connected Health & Intelligent Monitoring: The sector is moving away from static hardware in favor of Internet of Medical Things (IoMT) ecosystems. Modern drug delivery tools, such as smart inhalers and digital autoinjectors, now feature embedded sensors that link directly to clinical platforms. This allows for real-time tracking of patient adherence and supports the transition toward value-based healthcare models.

· Advanced Biologic Delivery Systems: The proliferation of complex biologics and biosimilars has fueled the adoption of On-Body Delivery Systems (OBDS). These wearable "patch pumps" are specifically engineered to manage high-viscosity, high-volume medications, enabling patients to transition intensive treatments from clinical settings to the comfort of their homes.

· Human-Centric Design for Home Care: To alleviate the financial strain on the U.S. healthcare infrastructure, manufacturers are prioritizing Human Factors Engineering (HFE). By creating intuitive, foolproof interfaces, companies are making self-administration a viable reality for elderly and remote populations, effectively lowering hospital readmission rates.

· Precision Targeting at the Nano-Scale: Breakthroughs in nanocarrier technologies, such as lipid nanoparticles (LNPs), are optimizing how drugs reach their targets. These systems increase bioavailability while significantly reducing systemic side effects. This is particularly vital in oncology, where localized "payload" delivery to specific tumor sites is becoming a standard therapeutic approach.

The industry is converging on a future where drug administration is seamless, intelligent, and designed to fit invisibly into the patient's daily routine.

U.S. Drug Delivery Devices Market Analysis

By Product Type

Oral drug delivery dominates due to high patient acceptability, cost-efficient production, and large-scale manufacturing feasibility.

Based on product type, the US drug delivery devices market is segmented into Injectable Drug Delivery Devices (Syringes, auto-injectors, pen injectors, infusion pumps), Inhalation Drug Delivery Devices (Metered-dose inhalers, dry powder inhalers, nebulizers), Transdermal Drug Delivery Devices (Transdermal patches), Oral Drug Delivery Systems (Controlled-release and advanced oral delivery technologies), Ocular Drug Delivery Devices, Nasal Drug Delivery Devices, Implantable Drug Delivery Devices. Among these, the injectable segment accounted for the largest share, contributing approximately 43.27% of the market in 2025.

By Application

Diabetes emerges as the most dominating application segment supported by growing insulin demand and self-administration trends

Based on application, diabetes holds the largest share of the drug delivery devices market due to the continuous need for insulin delivery and self-care treatments. Oncology is the fastest-growing segment, supported by rising cancer prevalence and advancements in targeted therapies, while cardiovascular and other applications contribute to stable growth.

By End-use

Hospitals dominate the market with strong demand for safe, high-volume drug administration and critical care delivery systems

Based on end-use, hospitals dominate the market due to extensive use of drug delivery systems in patient care. However, home healthcare is the fastest-growing segment, driven by self-administration trends and chronic disease management. Ambulatory settings also contribute steadily by supporting intermediate care needs.

Key Companies Profiled

The competitive landscape of the U.S. drug delivery devices market is characterized by strong competition among established manufacturers and emerging innovators. Key players such as BD, Medtronic, Novo Nordisk, and West Pharmaceutical Services collectively hold a major share of the U.S. market, supported by their advanced injectable platforms and continuous device innovation. Meanwhile, other companies are expanding through strategic collaborations, wearable delivery solutions, and integration of connected healthcare technologies.

The market is also witnessing the emergence of local manufacturers offering cost-effective inhalation, transdermal, and injectable drug delivery devices. Additionally, increasing investments in smart injectors, digital inhalers, biologics-compatible packaging, and patient-centric home care delivery systems are intensifying competition, pushing companies to enhance safety, improve adherence, and support next-generation therapies.

U.S. Drug Delivery Devices Market Companies:

Several prominent players driving innovation and growth in the U.S. drug delivery devices industry are as follows:

  • Becton Dickinson and Company

  • Pfizer Inc.

  • Merck & Co. Inc.

  • 3M

  • Johnson & Johnson

  • Medtronic plc

  • West Pharmaceutical Services, Inc.

  • Baxter International Inc

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the U.S. drug delivery devices market by-

  • Product Type (Revenue in USD Million, 2021 - 2035)

    • Oral Drug Delivery Devices

      • Controlled-release Tablets and Capsules

      • Buccal and Sublingual Tablets Camera Systems

    • Injectable Drug Delivery Devices

      • Prefilled Syringes

      • Auto-injectors

      • Pen injectors

      • Needle-free Injectors

      • Wearable Injectors

    • Inhalation Drug Delivery Devices

      • Metered Dose Inhalers

      • Dry Powder Inhalers

      • Soft Mist Inhalers

      • Nebulizers

    • Transdermal Drug Delivery Devices

      • Transdermal Patches

      • Iontophoresis Devices

      • Microneedle Patches

    • Nasal Drug Delivery Devices

      • Nasal Spray Pumps

      • Nasal Drops

      • Nasal Powder Devices

    • Ocular Drug Delivery Devices

      • Eye Drop Dispensers

      • Ocular Inserts

      • Drug-eluting Contact Lenses

    • Implantable Drug Delivery Devices

      • Drug-eluting Implants

      • Infusion Pumps

      • Biodegradable Implants

  • Application (Revenue in USD Million, 2021 - 2035)

    • Oncology

    • Infectious Diseases

    • Respiratory Diseases

    • Diabetes

    • Cardiovascular Diseases

    • Autoimmune Diseases

    • Central Nervous System Disorders

    • Others

  • End-use (Revenue in USD Million, 2021 - 2035)

    • Hospitals

    • Diagnostic Centers

    • Ambulatory Surgery Centers/Clinics

    • Home Care Settings

    • Others

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Value Chain Analysis

3.5. Technology Roadmap

3.6. Porters Analysis

3.7. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Oral Drug Delivery Devices

4.1.1. Controlled-release Tablets and Capsules

4.1.2. Buccal and Sublingual Tablets Camera Systems

4.2. Injectable Drug Delivery Devices

4.2.1. Prefilled Syringes

4.2.2. Auto-injectors

4.2.3. Pen injectors

4.2.4. Needle-free Injectors

4.2.5. Wearable Injectors

4.3. Inhalation Drug Delivery Devices

4.3.1. Metered Dose Inhalers

4.3.2. Dry Powder Inhalers

4.3.3. Soft Mist Inhalers

4.3.4. Nebulizers

4.4. Transdermal Drug Delivery Devices

4.4.1. Transdermal Patches

4.4.2. Iontophoresis Devices

4.4.3. Microneedle Patches

4.5. Nasal Drug Delivery Devices

4.5.1. Nasal Spray Pumps

4.5.2. Nasal Drops

4.5.3. Nasal Powder Devices

4.6. Ocular Drug Delivery Devices

4.6.1. Eye Drop Dispensers

4.6.2. Ocular Inserts

4.6.3. Drug-eluting Contact Lenses

4.7. Implantable Drug Delivery Devices

4.7.1. Drug-eluting Implants

4.7.2. Infusion Pumps

4.7.3. Biodegradable Implants

5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

5.1. Oncology

5.2. Infectious Diseases

5.3. Respiratory Diseases

5.4. Diabetes

5.5. Cardiovascular Diseases

5.6. Autoimmune Diseases

5.7. Central Nervous System Disorders

5.8. Others

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Diagnostic Centers

6.3. Ambulatory Surgery Centers/Clinics

6.4. Home Care Settings

6.5. Others

7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)

7.1.1. U.S.

7.1.1.1. U.S. Drug Delivery Devices Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Becton Dickinson and Company

8.5.2. Pfizer Inc.

8.5.3. Merck & Co. Inc.

8.5.4. 3M

8.5.5. Johnson & Johnson

8.5.6. Medtronic plc

8.5.7. West Pharmaceutical Services, Inc.

8.5.8. Baxter International Inc

8.6. Key Development Strategies

8.6.1. New Product Launches

8.6.2. Mergers and Acquisition

8.6.3. Partnerships and Collaborations

8.6.4. Expansion Plans

9. Analyst Perspective

10. Related Reports

Related Research

Global Vaginal Rejuvenation Market Size, Share, and Industry Analysis – by Treatment Type, by Type, by Application, and by Age Group – Growth and Trend Forecast, 2026 -2035

May 14, 2026View

Global Facial Implants Market Size, Share, and Industry Analysis – by Implant Type, by Application, and by End-use – Growth and Trend Forecast, 2026 -2035

May 9, 2026View

Global Orthopedic Devices Market Size, Share, and Industry Analysis – by Product Type and by End-use – Growth and Trend Forecast, 2026 -2035

May 9, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.